Share

December 2014; 1 (4) Clinical/Scientific NotesOpen Access

Leptomeningeal inflammation in rheumatoid arthritis

Simona Lattanzi, Claudia Cagnetti, Paolo Di Bella, Marina Scarpelli, Mauro Silvestrini, Leandro Provinciali
First published November 20, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000043
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
870

Share

Article Information

vol. 1 no. 4 e43
DOI: 
https://doi.org/10.1212/NXI.0000000000000043
PubMed: 
25419538
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received June 2, 2014
  • Accepted in final form October 13, 2014
  • First Published November 20, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Simona Lattanzi, MD,
    2. Claudia Cagnetti, MD,
    3. Paolo Di Bella, MD,
    4. Marina Scarpelli, MD,
    5. Mauro Silvestrini, MD and
    6. Leandro Provinciali, MD
  1. Simona Lattanzi, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Claudia Cagnetti, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Paolo Di Bella, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Marina Scarpelli, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Mauro Silvestrini, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Leandro Provinciali, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurological Clinic, Department of Experimental and Clinical Medicine (S.L., C.C., P.D.B., M. Silvestrini, L.P.) and Institute of Pathological Anatomy and Histopathology (M. Scarpelli), Marche Polytechnic University, Ancona, Italy.
  1. Correspondence to Dr. Lattanzi: alfierelattanzisimona{at}gmail.com

Article usage

Article usage: November 2014 to November 2023

AbstractFullPdfSource
Nov 2014511814Highwire
Dec 201418415968Highwire
Jan 20154129627Highwire
Jan 20150172pmc
Feb 2015122911Highwire
Feb 20150135pmc
Mar 201515273Highwire
Mar 20150178pmc
Apr 20155183Highwire
Apr 20150104pmc
May 201515175Highwire
May 20150124pmc
Jun 201514217Highwire
Jun 20150185pmc
Jul 2015899Highwire
Jul 2015042pmc
Aug 201533149Highwire
Aug 20150164pmc
Sep 2015495Highwire
Sep 20150162pmc
Oct 20159102Highwire
Oct 20150115pmc
Nov 2015532Highwire
Nov 2015043pmc
Dec 2015350Highwire
Dec 20150153pmc
Jan 20161683Highwire
Jan 2016095pmc
Feb 20161056Highwire
Feb 20160122pmc
Mar 2016975Highwire
Mar 20160170pmc
Apr 2016351Highwire
Apr 2016091pmc
May 2016973Highwire
May 20160125pmc
Jun 201621310Highwire
Jun 20160199pmc
Jul 20169100Highwire
Jul 2016079pmc
Aug 20161067Highwire
Aug 20160100pmc
Sep 20161010Highwire
Sep 2016092pmc
Oct 2016833Highwire
Oct 2016063pmc
Nov 2016913Highwire
Nov 20160103pmc
Dec 20161031Highwire
Dec 20160106pmc
Jan 20171133Highwire
Jan 20170113pmc
Feb 2017500Highwire
Feb 20170193pmc
Mar 2017911Highwire
Mar 20170123pmc
Apr 2017713Highwire
Apr 201752021pmc
May 2017512Highwire
May 2017178pmc
Jun 2017110Highwire
Jun 201711314pmc
Jul 2017200Highwire
Jul 201791522pmc
Aug 2017422Highwire
Aug 201711112pmc
Sep 2017243Highwire
Sep 201731515pmc
Oct 2017541Highwire
Oct 201731216pmc
Nov 2017442Highwire
Nov 201701721pmc
Dec 2017192Highwire
Jan 2018161Highwire
Feb 2018052Highwire
Mar 2018082Highwire
Apr 20181123Highwire
Apr 201832326pmc
May 20180121Highwire
Jun 20180213Highwire
Jun 201821820pmc
Jul 20180253Highwire
Aug 20181341Highwire
Aug 201832328pmc
Sep 20180121Highwire
Oct 20180264Highwire
Nov 20181471Highwire
Dec 20180530Highwire
Jan 20191431Highwire
Feb 20191431Highwire
Mar 20192185Highwire
Apr 20191123Highwire
May 20192205Highwire
Jun 2019174Highwire
Jul 20191163Highwire
Aug 20191136Highwire
Sep 2019183Highwire
Oct 20190164Highwire
Nov 2019062Highwire
Dec 2019053Highwire
Jan 20203176Highwire
Feb 20200116Highwire
Mar 2020166Highwire
Apr 20200111Highwire
May 20200184Highwire
Jun 2020162Highwire
Jul 20200135Highwire
Aug 20201125Highwire
Sep 2020296Highwire
Oct 20201103Highwire
Nov 2020274Highwire
Dec 20204121Highwire
Jan 20211178Highwire
Feb 2021053Highwire
Mar 2021088Highwire
Apr 20212123Highwire
May 20211183Highwire
Jun 20210170Highwire
Jul 202111311Highwire
Aug 20211225Highwire
Sep 20211175Highwire
Oct 202102616Highwire
Nov 202102817Highwire
Dec 202102911Highwire
Jan 20220294Highwire
Feb 20220278Highwire
Mar 20220151Highwire
Apr 20221225Highwire
May 202201415Highwire
Jun 20220235Highwire
Jul 20220170Highwire
Aug 20221305Highwire
Sep 202213620Highwire
Oct 20220227Highwire
Nov 202206221Highwire
Dec 20221173Highwire
Jan 20230328Highwire
Feb 20230224Highwire
Mar 20230183Highwire
Apr 20230153Highwire
May 20231187Highwire
Jun 20230194Highwire
Jul 20230184Highwire
Aug 20232107Highwire
Sep 2023082Highwire
Oct 20231162Highwire
Nov 20231141Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles